BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Genentech, Inc., Biogen Idec, Inc. (Massachusetts) Says Phase II/III Study Of Rituxan Fails To Meet Endpoints

  April 29, 2008

   · 

  10 min read
• Drug Development

  Inhibitex, Inc. Initiates Phase I Trial of FV-100 for the Treatment of Shingles

  April 29, 2008

   · 

  1 min read
• Biotech Beach

  Illumina, Inc. to Present at Upcoming Investment Conferences in May

  April 29, 2008

   · 

  1 min read
• Business

  bioMerieux SA - First Quarter 2008 Business Review

  April 29, 2008

   · 

  1 min read
• BioMidwest

  Biotechnology Industry Organization (BIO) Release: Sustainability Is Watchword for Industry, Say Speakers at World Congress on Industrial Biotechnology

  April 29, 2008

   · 

  1 min read
• Business

  Geron Corporation Announces Conference Call to Discuss Financial Results for the 2008 First Quarter

  April 29, 2008

   · 

  1 min read
• Drug Development

  Rigel Pharmaceuticals, Inc.'s R788 Slows Progression of Murine Lupus in Preclinical Studies

  April 29, 2008

   · 

  4 min read
• Business

  Sangamo BioSciences, Inc. Nominates Thomas G. Wiggans to Its Board of Directors

  April 29, 2008

   · 

  5 min read
• Policy

  Merck & Co., Inc. Receives Not Approvable Letter from FDA for MK-0524A (ER niacin/laropiprant)

  April 29, 2008

   · 

  3 min read
• CryoCath Technologies Inc. Achieves Key Milestone of 270 Consented Patients for STOP AF IDE Trial

  April 29, 2008

   · 

  1 min read